GSK Looks For New Chair To Lead It Through New Strategic Direction
Executive Summary
GSK’s non-exec chairman steps down from the UK firm, just a month after announcing a split that will reshape the company.
You may also be interested in...
Pfizer Consumer Combo Deal Frees Capital For GSK Pharma Investment
Separating out its consumer business in a joint venture with Pfizer will open up investment possibilities for GlaxoSmithKline's pharma and vaccine businesses.
New CFO Mackay Completes Top Table At GSK
CEO Emma Walmsley’s plans to transform the leadership at GSK have advanced again with the appointment of HSBC's Iain Mackay as the firm's new chief financial officer.
Welcome To Alexion 2.0
In an exclusive interview, Alexion R&D head John Orloff takes In Vivo on a tour around the company’s rejuvenated pipeline and explains how the business is innovating to pre-empt the Soliris-shaped hole in its balance sheet.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available Buy Reports
Need a specific report? 1000+ reports available Buy Reports